3-(Trimethylstannyl)benzyl alcohol was coupled in a Mitsunobu reaction with bis(Boc)-guanidine to give bis(Boc)-protected 3-(trimethylstannyl)benzylguanidine used as precursor for [*I]MIBG. Radioiodination with [ 131 I]iodine generated from [ 131 I]NaI and chloramine-T, removal of Boc groups, and purification by HPLC gave no-carrier-added tracer [*I]MIBG (81% radiochemical yield, 99% chemical purity) used for imaging tumors of neuroendocrine origin. The structures of bis(Boc)-guanidine and bis(Boc)-protected 3-(trimethylstannyl)benzylguanidine were secured by single crystal X-ray structure analyses.
m-Iodobenzylguanidine (MIBG) labeled with radioiodine 131 I or 123 I is an analogue of the andrenergic neuron-blocking agent guanethidine and of norepinephrine being mainly biosynthesized in the adrenal medulla. 1 Since 1980 [*I]MIBG is well-established in diagnostic scintigraphy and widely applied in imaging tumors of neuroendocrine origin, particularly neuroblastoma and pheochromocytoma. [2] [3] [4] [*I]MIBG as a norepinephrine analogue is concentrated in the myocardium and has been used for severity assessment of cardiac diseases. 5 Labeled [ 131 I]MIBG is also effective in the therapeutic treatment of pediatric neuroblastoma. 6 Currently, [*I]MIBG, routinely applied in clinical diagnostic imaging and therapy, is prepared by nucleophilic isotope exchange reaction. This kind of radiopharmaceutical preparation may contain a pharmaceutically significant amount of cold MIBG (1-5 mg). 7 The first published labeling method was based on a solidphase radioiodine exchange reaction assisted by ammonium sulfate. 8 Later several modifications of this method have been reported. The isotope exchange was also catalyzed by Cu(I) in the presence of a reducing agent such as Sn(II), ascorbic acid, 2,5-dihydroxybenzoic acid, or sodium metabisulfite. [9] [10] [11] Instead of a solid-phase reaction, the labeling of MIBG can be performed in refluxing glacial acetic acid. 10, 12 However, the synthesis of [*I]MIBG via isotope exchange reaction has some distinct disadvantages. Firstly, byproducts such as radiolabeled iodobenzylamine may be formed as impurities during the radioiodination. 11 Secondly, due to the method of preparation the formulation contains a considerable amount of unlabeled cold MIBG, which may influence the pharmacokinetics of the radiolabeled form. 2 Therefore, it would be advantageous to prepare [*I]MIBG containing virtually no cold MIBG. The first reported approaches to synthesize no-carrier-added [*I]MIBG relied on a tributylstannyl-or silyl-substituted precursor. 13 In the latter case, radiochemical yields varied from 85-90% in addition to the formation of benzyl-, 3chloro-, and 3-fluorobenzylguanidine as by-products. Recently, N,N′-bis(tert-butoxycarbonyl)-N-(3-trimethylstannylbenzyl)guanidine prepared from the corresponding iodo derivative by Pd-catalyzed stannylation as (impure) oils in 43% and 57% yield, respectively, was used as precursor for iododestannylation. 14, 15 Our synthesis of [*I]MIBG is also based on iododestannylation of 3-(trimethylstannyl)benzylguanidine. 14, 15 Initially, the preparation of this precursor was tried in two steps by a literature procedure. 16 First, 3-iodobenzylamine was treated with hexamethylditin and tetrakis(triphenylphosphine)palladium(0) to obtain the corresponding 3-(trimethylstannyl)benzylamine, which was described as a crystalline solid (mp 78°C). 16 However, it was found to be an oil (bp 98°C/1 mmHg), which was also supported by literature. 17 Furthermore, the yield of stannylation was unsatisfactorily low (25%). The second step was the conversion of the amine with cyanamide in the presence of a catalytic amount of HCl to the guanidine, which was claimed to be an oil. We repeated this transformation, but the result was inconclusive.
Therefore, it was decided to prepare the amine and the guanidine by a different approach (Scheme 1). Halogenmetal exchange in 3-iodobenzyl alcohol (1a) with t-BuLi (3.2 equiv) at -78°C in anhydrous THF followed by 1.5 equivalents of Me 3 SnCl gave at best 23% of 3-(trimethylstannyl)benzyl alcohol (2) . The yield could be increased to 69%, when t-BuLi was replaced by n-BuLi (3.2 equiv, 90 min, -78°C, 1.5 equiv of Me 3 SnCl, THF). The yield was even better (93%), when 3-bromobenzyl alcohol (1b) was used as the substrate (2.3 equiv of n-BuLi for halogen-lithium exchange at -78°C in THF for 90 min, 2.1 equiv of Me 3 SnCl). This method was used previously for the preparation of 3-(tributylstannyl)benzyl alcohol. 18
Scheme 1 Synthesis of precursor 6
The 3-(trimethylstannyl)benzyl alcohol (2) was converted into the azide 17 3 by the Mitsunobu reaction 19 in 82% yield and then reduced 17 to the oily benzylamine 4 in 70% yield. The amine had been prepared earlier from (3-bromobenzyl)dimethylamine by Koldobsky et al. in three steps. 17 The guanidinylation of 4 could have been effected, for example, by reaction with cyanamide, 16 Mukaiyama's reagent, and thioureas, 20 or N,N′-bis(tert-butoxycarbonyl)-N′′-triflylguanidine. 21 None of this method was tried, as it had been found 22 in the meantime that the Mitsunobu reaction of alcohol 2 with N,N′-bis(tert-butoxycarbonyl)guanidine could give a protected precursor in high yield, which could be purified by flash column chromatography. Alternatively, the benzyl alcohol could be transformed into the bromide, which is then reacted with the sodium salt of N,N′-bis(tert-butoxycarbonyl)guanidine. 23 As the Mitsunobu reaction was our first choice, the protected guanidine was prepared first and the literature procedures were optimized (Scheme 2). Commercially available S-mehylisothiourea hemisulfate was Bocprotected 24 in 91% yield in the biphasic system NaHCO 3 /H 2 O/Boc 2 O/CH 2 Cl 2 . N-tert-Butoxycarbonylmethylisothiourea (8), formed as a side product (8%), could be removed easily by flash chromatography. Exchange of the methylthio group for amine with ammonia in methanol furnished the bis(Boc)-protected guanidine 9a in 95% yield. 22 Interestingly, Feichtinger et al. reported that 9b was formed from guanidine and Boc 2 O under strong alkaline conditions in 59% yield. 21 In the literature, structures 19, 22 9a and in one case 21 9b are given for bis(Boc)-guanidine without providing evidence. To solve this ambiguity, a single crystal X-ray analysis was per-formed proving structure 9a for the solid state ( Figure 1 ). We assume that this is also the structure of bis(Boc)guanidine in solution. Finally, 9a and 3-(trimethylstannyl)benzyl alcohol (2) were reacted in a Mitsunobu reaction with Ph 3 P/DIAD (diisopropyl azodicarboxylate) in anhydrous toluene to give the desired precursor 10, which was isolated by flash chromatography (87%) (Scheme 3). 22 Satisfyingly, precursor 10 crystallized (from hexanes) to give colorless crystals. The same precursor had been prepared earlier as an oil by the reaction of 3-iodobenzyl bromide with the sodium salt of bis(Boc)-guanidine, followed by exchange of the iodine for trimethyltin using Pd(Ph 3 P) 4 /Me 6 Sn 2 (57%). 15 Iododestannylation and removal of protecting groups furnished the tracer.
When this work was finished, we found that the bis(Boc)protected guanidine is commercially available. Thus, our synthesis comprises just two steps starting from 3-bromobenzyl alcohol, which is also commercially available.
As the precursor was described as an oil 14, 15 (chemical purity 94%) in the literature and ours was crystalline, and although the 1 H NMR spectra were virtually identical, we decided to perform a single crystal X-ray structure analysis ( Figure 2 ). Satisfyingly, it proved the structure of com- pound 10 as given in Scheme 3, which is also in line with 9a. The molecular structure is stabilized by two short internal hydrogen bonds (N···O = 2.57 and 2.61 Å; Figure  2 ), which control its conformation. This result shows that compound 13, an isomer of 10, is not formed (Figure 3 ). The nucleophile derived from 9 in the Mitsunobu reaction is the one obtained by deprotonation at the nitrogen atom attached to a Boc group. Radioiodination of the precursor N,N′-bis(Boc)-N-(3-trimethylstannylbenzyl)guanidine (10) with no-carrieradded [ 123 I]NaI and N-chlorosuccinimide (NCS) as an in situ oxidizing agent has been recently reported. Rossouw et al. described the use of 2000 μg of NCS as an oxidanta 10-fold mass excess relative to precursor 10 -which appeared to us as nonoptimal. We argued that the large excess of NCS could interfere with the final purification of the tracer by HPLC or by using a solid phase cartridge. Therefore, it was decided to replace NCS with chloramine-T, also a well known oxidizing agent. 25 In conclusion, we have developed a concise synthesis of a trimethylstannylated precursor, which allows a no-carrier-added labeling with radioiodine to form [*I]MIBG. As a novel approach, the radiolabeling reaction was carried out successfully using chloramine-T as oxidant. It was shown that the [*I]MIBG could be obtained in high yield and purity under mild reaction conditions. The labeling process appears to be amenable for automation, which is applicable to all radioiodine isotopes and allows large scale routine production of [*I]MIBG for radiopharmaceutical use. 
Radiosynthesis
No-carrier-added [ 131 I]NaI in 0.1 M NaOH was obtained from PerkinElmer (Boston, MA, USA). The radioactivity was measured in a Capintec CRC-15 dose calibrator (Ramsey, NJ, USA). Analytical high-performance liquid chromatography (HPLC) analyses were performed on an Agilent 1200 system (Böblingen, Germany) equipped with a quaternary pump, autosampler, and a variable wavelength spectrophotometer, which was connected in series with a Raytest radioactivity detector (Straubenhardt, Germany). Data were collected by Raytest radio chromatography software. Radio-TLCs were evaluated using an electronic autoradiograph (Canberra-Packard, Watford, UK).
3-(Trimethylstannyl)benzyl Alcohol (2)
n-BuLi (5.75 mL, 9. Anal. Calcd for C 10 
N,N′-Bis(tert-butoxycarbonyl)-S-methylisothiourea (7)
A mixture of S-methylisothiuronium hemisulfate (5; 1.392 g, 10.0 mmol), di(tert-butyl) dicarbonate (4.36 g, 20 mmol, 2 equiv), CH 2 Cl 2 (25 mL), and sat. aq NaHCO 3 (25 mL) was vigorously stirred for 3 days at r.t. The layers were separated, and the aqueous phase was extracted with CH 2 Cl 2 (3 × 20 mL The 1 H NMR spectrum is identical with that of literature; 21 no 13 C NMR and IR spectra were given.
Crystal Structure 30
Crystal data: C 11 
N,N′-Bis(tert-butoxycarbonyl)-N-(3-trimethylstannylbenzyl)guanidine (10)
A solution of N,N′-bis(tert-butoxycarbonyl)guanidine (9a; 0.583 g, 2.252 mmol, 2 equiv) and Ph 3 P (0.443 g, 1.689 mmol, 1.5 equiv) in anhyd toluene (10 mL) was cooled in an ice bath under argon. 3-(Trimethylstannyl)benzyl alcohol (2; 0.305 g, 1.126 mmol) dissolved in anhyd toluene (2 mL) and DIAD (0.321 g, 0.31 mL, 1.689 mmol, 1.5 equiv) were added and the stirring was continued for 5 h at r.t. (TLC: hexanes-EtOAc, 5:1, R f = 0.85). The solvent was evaporated under reduced pressure and the residue was purified by flash chromatography (CH 2 Cl 2 -hexanes, 3:1) to give precursor 10 (0.503 g, 87%) as colorless crystals; mp 89-90°C (hexanes, r.t. to -18°C). 
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